SMITH & NEPHEW PLC |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 958.3 GBX | -0.88% |
|
-0.34% | -11.18% |
| Apr. 11 | UK Stocks Retreat as Hope for June BoE Rate Cut Dissipates | MT |
| Apr. 11 | Proxy Advisers Raise Concerns Over Smith & Nephew's Pay Hike Proposal | MT |
Presenter SpeechDeepak Nath (Executives)I'll just draw your attention to the safe harbor state...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Smith & Nephew Plc specializes in designing, manufacturing and marketing medical products and equipment. Net sales break down by activity sector as follows:
- orthopedic surgery (39.9%): primarily orthopedic implants (hips, knees and shoulders);
- sports medicine, arthroscopy and cervicofacial surgery (31.2%): surgery and damaged tissue repair products and instruments, visualization products, etc.;
- wound care (28.9%): skin grafts for major burns victims, treatments for leg ulcers, etc.
The United States accounts for 53.7% of net sales.
Calendar
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
12.05
USD
Average target price
16.43
USD
Spread / Average Target
+36.34%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -11.18% | 10.51B | |
| +9.35% | 125B | |
| -1.13% | 8.65B | |
| +18.54% | 7.31B | |
| +19.68% | 4.77B | |
| +7.75% | 3.42B | |
| -1.34% | 3.03B | |
| -16.08% | 1.97B | |
| -12.31% | 1.95B | |
| -30.20% | 1.62B |
- Stock Market
- Equities
- SN. Stock
- News Smith & Nephew Plc
- Transcript : Smith & Nephew plc, H1 2022 Earnings Call, Jul 28, 2022
